Skip to main content
. 2022 Dec 8;2(3):e92. doi: 10.52225/narra.v2i3.92

Figure 4.

Figure 4.

The genomic organization of SARS-CoV-2 along with the major drug targets that can be utilized for developing SARS-CoV-2 specific therapeutics.